Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) (T-BSDB-159)

Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can induce targeted apoptosis. It is designed for the research of Melanoma therapy.

Datasheet INQUIRY

Specifications

Targets

FAS & CSPG4

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Melanoma

Targets

Target 1

FAS

Gene ID

355

UniProt ID

P25445

Alternative Names

APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6; FAS; Fas cell surface death receptor

Target 2

CSPG4

Gene ID

1464

UniProt ID

Q6UVK1

Alternative Names

NG2; Neuron-glial antigen 2; Melanoma-associated chondroitin sulfate proteoglycan; chondroitin sulfate proteoglycan 4; CSPG4; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) (T-BSDB-159). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-159)

Specifications

Targets

Customer Reviews and Q&As